MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe
LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
NEWS HIGHLIGHTS Multi-generational agreement advances Intel’s IDM 2.0 strategy. Partnership broadens and accelerates IP access…
HONG KONG, Aug 16, 2023 – (ACN Newswire) – Impro Precision (01286.HK), the world’s sixth…
HONG KONG, Aug 16, 2023 – (ACN Newswire) – Kingworld Medicines Group Limited (“Kingworld Medicines”…
SAN DIEGO–(BUSINESS WIRE)–$APLD #APLD—Robbins LLP informs investors that a shareholder filed a class action on…
Gross margin nearly doubles to 37% for the quarter ended June 30, 2023, improving 1,800…
MISSISSAUGA, Ontario, Aug. 15, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
MISSISSAUGA, Ontario, Aug. 15, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
PARIS and CAMBRIDGE, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ:…
PARIS and CAMBRIDGE, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ:…
SAN MATEO, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT),…
SAN MATEO, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT),…
EscharEx® Phase III study protocol: FDA/EMA-aligned; patient enrollment commencing early 2024; two key research collaborations…
EscharEx® Phase III study protocol: FDA/EMA-aligned; patient enrollment commencing early 2024; two key research collaborations…
MediWound joins forces with one of the largest global chronic wound companies in pivotal study…
MediWound joins forces with one of the largest global chronic wound companies in pivotal study…
Approximately 71% of Stockholders Voted in Favor of the TransactionDiffusion Announces 1-for-1.5 Reverse Stock SplitMerger…
MediWound to join forces with leading chronic wound allograft company in pivotal study for patients…
Information concerning the total number of voting rights and shares, provided pursuant to article L….
Dual Performance Trigger and Dual15 Plus available with Lincoln Level Advantage® registered indexed-linked annuity offer…